Literature DB >> 30896193

The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disorders.

Liqa N Athamneh1, William B DeHart1, Derek Pope1, Alexandra M Mellis1, Sarah E Snider1, Brent A Kaplan1, Warren K Bickel1.   

Abstract

Abstinence self-efficacy (ASE) and delay discounting predict treatment outcomes and risk of relapse. Associations between delay discounting and ASE among individuals in recovery from substance use have not been investigated. Data from 216 individuals in recovery from substance abuse recruited from The International Quit & Recovery Registry, an ongoing online data collection program used to understand addiction and how people succeed in recovery, were included in the analysis. Discounting rates were assessed using an adjusting-delay task, and ASE was assessed using the Relapse Situation Efficacy Questionnaire (RSEQ). Delay discounting was a significant predictor of ASE, even after controlling for age, gender, race, ethnicity, annual income, education level, marital status, and primary addiction. Context-specific factors of relapse included Negative Affect, Positive Affect, Restrictive Situations (to drug use), Idle Time, Social-Food Situations, Low Arousal, and Craving. A principal component analysis of RSEQ factors in the current sample revealed that self-efficacy scores were primarily unidimensional and not situation specific. The current study expands the generality of delay discounting and indicates that discounting rates predict ASE among individuals in recovery from substance use disorders. This finding supports the recent characterizations of delay discounting as a candidate behavioral marker of addiction and may serve as a basis to better identify and target subgroups that need unique or more intensive interventions to address higher risks of relapse and increase their likelihood of abstinence. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 30896193      PMCID: PMC6483840          DOI: 10.1037/adb0000460

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  61 in total

1.  Drug treatment and 12-step program participation: the additive effects of integrated recovery activities.

Authors:  R Fiorentine; M P Hillhouse
Journal:  J Subst Abuse Treat       Date:  2000-01

2.  Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls.

Authors:  N M Petry
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

3.  Impulsive and/or planned behaviour: can impulsivity contribute to the predictive utility of the theory of planned behaviour?

Authors:  Sue Churchill; Donna Jessop; Paul Sparks
Journal:  Br J Soc Psychol       Date:  2008-02-15

4.  Self-efficacy for cocaine abstinence: pretreatment correlates and relationship to outcomes.

Authors:  Sara L Dolan; Rosemarie A Martin; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2007-12-07       Impact factor: 3.913

5.  Self-efficacy and smoking reexamined: construct validity and clinical utility.

Authors:  J S Baer; C S Holt; E Lichtenstein
Journal:  J Consult Clin Psychol       Date:  1986-12

6.  Addiction and discounting.

Authors:  A L Bretteville-Jensen
Journal:  J Health Econ       Date:  1999-08       Impact factor: 3.883

7.  Social cognitive mediators of adolescent smoking cessation: results from a large randomized intervention trial.

Authors:  Jonathan B Bricker; Jingmin Liu; Bryan A Comstock; Arthur V Peterson; Kathleen A Kealey; Patrick M Marek
Journal:  Psychol Addict Behav       Date:  2010-09

8.  Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.

Authors:  Peter S Hendricks; Kevin L Delucchi; Sharon M Hall
Journal:  Drug Alcohol Depend       Date:  2010-01-21       Impact factor: 4.492

9.  Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting.

Authors:  Henry Lin; Leonard H Epstein
Journal:  Behav Neurosci       Date:  2014-02       Impact factor: 1.912

10.  A randomized controlled trial of directive and nondirective smoking cessation coaching through an employee quitline.

Authors:  Walton Sumner; Mark S Walker; Gabrielle R Highstein; Irene Fischer; Yan Yan; Amy McQueen; Edwin B Fisher
Journal:  BMC Public Health       Date:  2016-07-11       Impact factor: 3.295

View more
  6 in total

1.  The phenotype of recovery VII: Delay discounting mediates the relationship between time in recovery and recovery progress.

Authors:  William H Craft; Allison N Tegge; Liqa N Athamneh; Devin C Tomlinson; Roberta Freitas-Lemos; Warren K Bickel
Journal:  J Subst Abuse Treat       Date:  2021-11-15

2.  The phenotype of recovery V: Does delay discounting predict the perceived risk of relapse among individuals in recovery from alcohol and drug use disorders.

Authors:  Jamie K Turner; Liqa N Athamneh; Julia C Basso; Warren K Bickel
Journal:  Alcohol Clin Exp Res       Date:  2021-04-05       Impact factor: 3.455

3.  Evaluating effects of episodic future thinking on valuation of delayed reward in cocaine use disorder: a pilot study.

Authors:  Sarah E Forster; Stuart R Steinhauer; Andrea Ortiz; Steven D Forman
Journal:  Am J Drug Alcohol Abuse       Date:  2021-02-04       Impact factor: 3.829

4.  Considerations for remote delivery of behavioral economic interventions for substance use disorder during COVID-19 and beyond.

Authors:  Lara N Coughlin; Erin E Bonar; Warren K Bickel
Journal:  J Subst Abuse Treat       Date:  2020-10-04

5.  The phenotype of recovery IV: Delay discounting predicts perceived stress and a chance locus of control in individuals in recovery from substance use disorders.

Authors:  Devin C Tomlinson; Allison N Tegge; Liqa N Athamneh; Warren K Bickel
Journal:  Addict Behav Rep       Date:  2020-11-28

6.  Virtual reality intervention effects on future self-continuity and delayed reward preference in substance use disorder recovery: pilot study results.

Authors:  Yitong I Shen; Andrew J Nelson; Brandon G Oberlin
Journal:  Discov Ment Health       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.